FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.3099
-0.0039 (-1.24%)
At close: Mar 31, 2025, 4:00 PM
0.3125
+0.0026 (0.83%)
After-hours: Mar 31, 2025, 7:56 PM EDT
FibroGen Employees
FibroGen had 225 employees as of December 31, 2024. The number of employees decreased by 261 or -53.70% compared to the previous year.
Employees
225
Change (1Y)
-261
Growth (1Y)
-53.70%
Revenue / Employee
$131,649
Profits / Employee
-$211,462
Market Cap
31.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FGEN News
- 14 days ago - FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - Benzinga
- 5 weeks ago - FibroGen sells China unit to AstraZeneca in deal worth $160 million - Reuters
- 5 weeks ago - FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million - GlobeNewsWire
- 3 months ago - FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewsWire
- 4 months ago - FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha